Literature DB >> 3342374

The histologic diagnosis of adenocarcinoma in situ and related lesions of the cervix uteri. Adenocarcinoma in situ.

R C Jaworski1, N F Pacey, M L Greenberg, R A Osborn.   

Abstract

Seventy-two cases of in situ adenocarcinoma (AIS) of the cervix were reviewed. Forty-five cases had associated cervical intraepithelial neoplasia and 20 cases had changes of wart virus infection. Five cases had associated microinvasive squamous cell carcinoma and one cases showed frankly invasive squamous cell carcinoma (SCC). Of the 72 cases, 41 showed an endocervical type of AIS and three cases an endometrioid type. There was no case of pure intestinal type AIS. Twenty-eight cases showed a mixed pattern. Architectural patterns characterized by tunnel clusters, cribriform glands, glandular budding and papillary formations were assessed. Most cases showed varying combinations of these patterns but in ten cases significant changes were absent. Both cellular apoptosis and mitotic activity were seen in varying degrees in all cases of AIS. The significance of these and other features of AIS are discussed as well as the conditions involved in the differential diagnosis.

Entities:  

Mesh:

Year:  1988        PMID: 3342374     DOI: 10.1002/1097-0142(19880315)61:6<1171::aid-cncr2820610620>3.0.co;2-x

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  DNA ploidy in adenocarcinoma in situ of the uterine cervix.

Authors:  R C Jaworski; A Jones
Journal:  J Clin Pathol       Date:  1990-05       Impact factor: 3.411

Review 2.  [Precancerous lesions of the uterine cervix: morphology and molecular pathology].

Authors:  L-C Horn; K Klostermann
Journal:  Pathologe       Date:  2011-11       Impact factor: 1.011

3.  Conservative treatment of coexisting microinvasive squamous and adenocarcinoma of the cervix: report of two cases and literature review.

Authors:  Francesco Sopracordevole; Jacopo Di Giuseppe; Silvia Cervo; Monica Buttignol; Giorgio Giorda; Andrea Ciavattini; Vincenzo Canzonieri
Journal:  Onco Targets Ther       Date:  2016-01-27       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.